当前位置:首页 - 行情中心 - 广康生化(300804) - 财务分析 - 现金流量表

广康生化

(300804)

  

流通市值:10.14亿  总市值:27.29亿
流通股本:2750.00万   总股本:7400.00万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金303,683,812.06189,826,237.2891,069,802.74557,486,219.82
  收到的税费返还50,671,063.5545,667,996.229,787,532.3828,744,613.12
  收到其他与经营活动有关的现金7,278,207.125,325,298.091,575,835.375,016,552.58
  经营活动现金流入小计361,633,082.73240,819,531.59102,433,170.49591,247,385.52
  购买商品、接受劳务支付的现金262,604,729.81224,470,022.62111,785,590.69340,343,688.08
  支付给职工以及为职工支付的现金79,775,222.6354,313,702.9930,916,634.45104,058,954.49
  支付的各项税费1,117,877.53722,197.03374,606.298,788,933.8
  支付其他与经营活动有关的现金57,237,909.2634,763,627.4117,342,200.6457,136,480.64
  经营活动现金流出小计400,735,739.23314,269,550.05160,419,032.07510,328,057.01
  经营活动产生的现金流量净额-39,102,656.5-73,450,018.46-57,985,861.5880,919,328.51
二、投资活动产生的现金流量:
  收回投资收到的现金499,000,000369,000,000150,000,0002,202,000,000
  取得投资收益收到的现金3,457,163.792,537,091.19511,717.775,858,700.64
  处置子公司及其他营业单位收到的现金净额17,261,347.36---
  投资活动现金流入小计519,718,511.15371,537,091.19150,511,717.772,207,858,700.64
  购建固定资产、无形资产和其他长期资产支付的现金250,816,688.42173,653,125.13126,194,415.07231,548,308.38
  投资支付的现金249,000,458.0569,000,00039,000,0002,122,000,000
  投资活动现金流出小计499,817,146.47242,653,125.13165,194,415.072,353,548,308.38
  投资活动产生的现金流量净额19,901,364.68128,883,966.06-14,682,697.3-145,689,607.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金450,000450,000--
  其中:子公司吸收少数股东投资收到的现金450,000450,000--
  取得借款收到的现金347,979,179.46151,620,876.08110,496,876.08338,068,640.28
  收到其他与筹资活动有关的现金49,438,698.4537,457,239.6313,983,535.4243,107,081.46
  筹资活动现金流入小计397,867,877.91189,528,115.71124,480,411.5381,175,721.74
  偿还债务支付的现金186,999,603.42100,674,603.4294,519,882.21199,054,403.18
  分配股利、利润或偿付利息支付的现金20,144,296.9717,003,998.642,848,987.9510,978,161.84
  支付其他与筹资活动有关的现金28,732,993.8816,627,778.623,886,920.2855,941,142.33
  筹资活动现金流出小计235,876,894.27134,306,380.68101,255,790.44265,973,707.35
  筹资活动产生的现金流量净额161,990,983.6455,221,735.0323,224,621.06115,202,014.39
四、汇率变动对现金及现金等价物的影响-2,739,889.2-1,606,646.75-916,708.91,312,615.26
五、现金及现金等价物净增加额140,049,802.62109,049,035.88-50,360,646.7251,744,350.42
  加:期初现金及现金等价物余额173,460,018.23173,460,018.23173,460,018.23121,715,667.81
  期末现金及现金等价物余额313,509,820.85282,509,054.11123,099,371.51173,460,018.23
补充资料:
  净利润-4,209,974.5-40,417,901.23
  资产减值准备-2,764,755.85-2,283,946.97
  固定资产和投资性房地产折旧-39,954,494.17-65,735,771.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-39,954,494.17-65,735,771.25
  无形资产摊销-1,279,105.27-3,780,115.34
  长期待摊费用摊销-2,049,577.04-2,310,958.92
  处置固定资产、无形资产和其他长期资产的损失---15,128.49
  固定资产报废损失-1,402,985.28-3,212,438.76
  公允价值变动损失--81,351--289,556.61
  财务费用-11,080,699.87-10,533,618.9
  投资损失--1,656,990.04--6,368,040.75
  递延所得税--2,294,435.78--1,040,455.76
  其中:递延所得税资产减少--1,950,025.99--458,293.81
    递延所得税负债增加--344,409.79--582,161.95
  存货的减少--38,230,694.5--71,834,618.15
  经营性应收项目的减少--42,116,496.07--125,850,871.74
  经营性应付项目的增加--52,492,364.86-156,970,361.99
  其他-365,675.2--
  现金的期末余额-282,509,054.11-173,460,018.23
  减:现金的期初余额-173,460,018.23-121,715,667.81
  现金及现金等价物的净增加额-109,049,035.88-51,744,350.42
公告日期2026-10-242026-08-282026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑